Eisai appoints chief clinical officer

April 12, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Eisai

Eisai has announced the immediate appointment of Lynn Kramer to the newly created position of chief clinical officer of Eisai …

tamiflu

Cancer drugs boost Roche

April 12, 2013
Sales and Marketing Cancer, Q1, Roche

Roche saw overall sales rise 6% year-on-year in the first three months of this year on the back of a …

nhs_trees

Change at centre of NHS plan

April 12, 2013
Sales and Marketing Mid Staffs, NHS, putting patients first

The shadow of Mid Staffs looms long over NHS England’s new three-year business plan, with a move towards fundamental change …

roche_close

Roche signs Huntington’s deal

April 10, 2013
Research and Development, Sales and Marketing Huntington's, Isis, Roche

Roche is to pay California-based Isis Pharmaceuticals $30 million upfront to cement a new alliance in which the firms will …

Bristol-Myers Squibb appoints executive as another retires

April 10, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has announced the appointment of Francis Cuss as executive VP and chief scientific officer following Elliott Sigal’s intentions …

MedImmune buys AlphaCore

April 9, 2013
Research and Development AlphaCore, AstraZeneca, MedImmune

AstraZeneca’s biologics R&D arm MedImmune has bought private US biotech firm AlphaCore Pharma for an undisclosed sum.The acquisition is part …

Pharma pays doctors £40m

April 9, 2013
Sales and Marketing ABPI, Bad pharma, ethics

Health professionals received £40 million in payments from pharma companies last year, according to new figures released by the ABPI.This …

New head at European Medicines Agency

April 8, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA

The European Medicines Agency has appointed Agneta Brandt as the new head of Infrastructure Services. Brandt joins the Agency from …

abpi_reception

Ten pharma firms censured

March 28, 2013
Medical Communications, Sales and Marketing ABPI, PMCPA

Ten pharma companies have been found guilty by the PMCPA of failing to maintain high standards over their involvement in …

FDA image

US nod for Tecfidera

March 28, 2013
Sales and Marketing Biogen, FDA, tecfidera

The FDA has given Biogen Idec’s oral multiple sclerosis treatment Tecfidera the green light. Earlier this week Tecfidera (dimethyl fumarate) …

Star commercial academy appoints director

March 28, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Star

Gary Lunt has been appointed to the newly created role of Business Development director with training agency STAR Commercial Academy. …

New ‘culture of compassion’ for NHS

March 27, 2013
Sales and Marketing Francis, Francis report, Hunt, Mid Staffs, NHS, Staffs

The government has launched plans to ensure that the needs of patients are paramount in any future dealings with the …

GSK image

FDA delays GSK flu vaccine

March 27, 2013
Research and Development, Sales and Marketing FDA, GSK, Vaccine

The FDA has cooled on GlaxoSmithKline’s latest vaccine for a bird flu pandemic, Q-Pan H5N1, despite a vote of confidence …

biogen idec image

Multiple sclerosis rivals gain EU approval

March 27, 2013
Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS

Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …

stuart_mcguire_12a

Chiltern announces two promotions

March 26, 2013
Manufacturing and Production, Research and Development, Sales and Marketing chiltern

Global clinical contract research organisation Chiltern International has announced the promotions of Stuart McGuire and Jim Szymeczek.“I am pleased to …

crestor image

AstraZeneca settles Crestor case

March 26, 2013
Sales and Marketing AstraZeneca, Crestor, Watson

AstraZeneca has settled a long-running legal battle over one of its biggest brands, Crestor, whose patent expires in 2016. The …

sanofi image

Sanofi in immunotherapy tie-up

March 26, 2013
Research and Development, Sales and Marketing Transgene, snaofi

Sanofi has signed a 15-year deal with biopharma company Transgene to produce a platform to help create a range of …

Africa rising

March 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Lunt

Africa has been a byword for poverty, disease and political turmoil for generations, and many people in the most developed …

New chief executive for Eyevensys

March 26, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Eyevensys

Gene therapy development firm Eyevensys has announced the appointment of Dr Ivan Cohen-Tanugi as chief executive.Cohen-Tanugi has over 20 years’ …

Xarelto image

Xarelto gets EU nod

March 25, 2013
Sales and Marketing Bayer, Xarelto

Bayer HealthCare has been given a boost by the recommendation in Europe of its oral blood thinner Xarelto to prevent …

The Gateway to Local Adoption Series

Latest content